Shanghai Pharmaceuticals Announces Share Transfer, Maintains Control
hong Kong - Shanghai Pharmaceuticals Holding Co.,Ltd. (HK:2607) today announced a critically important equity adjustment involving the transfer of its entire equity interest in Shanghai Industrial Investment (Holdings) Company Limited to Golden Bell International Holdings Limited. The move reshapes the companyS shareholder structure, increasing the stake held by Shanghai Shangshi (Group) Co., ltd. from 25.303% to 38.487%.
Despite the change in share distribution, Shanghai SASAC remains the controlling shareholder and de facto controller of Shanghai Pharmaceuticals. According to the company, the adjustment adheres to all relevant regulations and does not trigger any mandatory tender or general offer obligations under Hong Kong’s Code on takeovers and Mergers.
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the Chinese pharmaceutical industry, focusing on industrial investment, domestic trade, and state-owned asset management. the company currently boasts a market capitalization of HK$77.63B with an average daily trading volume of 3,875,371 shares.
Analysts currently maintain a “Buy” rating on HK:2607, with a price target of HK$13.50. Technical sentiment signals currently indicate a “Strong Buy.” Further details on analyst forecasts and stock performance can be found on the TipRanks Stock Forecast page.
